Development and validation of a novel bleeding risk prediction tool for aspirin users with a low body mass index
Abstract Aspirin is commonly utilized in the management and prevention of various diseases. However, in specific individuals, particularly those with low body mass index (BMI), aspirin can elevate the risk of bleeding. Achieving a delicate equilibrium between the desirable antiplatelet effects and p...
Saved in:
Main Authors: | Lu Yifang, Lei Wanlin, Wang Maofeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88327-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention
by: Soo Hyun Kang, et al.
Published: (2025-01-01) -
Impact of pre-pregnancy body mass index on preeclampsia
by: Jing Mao, et al.
Published: (2025-02-01) -
Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention
by: Junyan Zhang, et al.
Published: (2025-01-01) -
Role of aspirin in cancer prevention
by: Meng Sun, et al.
Published: (2024-01-01) -
Association Analysis of Polymorphisms with Aspirin-Exacerbated Respiratory Disease in a Korean Population
by: Jin Sol Lee, et al.
Published: (2014-06-01)